{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:17:04Z","timestamp":1794489424313,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatocyte Nuclear Factor 1\u03b1 (HNF1\u03b1) is an atypical homeodomain-containing transcription factor that transactivates liver-specific genes including albumin, \u03b1-1-antitrypsin and \u03b1- and \u03b2-fibrinogen. Biallelic inactivating mutations of <jats:italic>HNF1A<\/jats:italic> have been frequently identified in hepatocellular adenomas (HCA), rare benign liver tumors usually developed in women under oral contraceptives, and in rare cases of hepatocellular carcinomas developed in non-cirrhotic liver. HNF1\u03b1-mutated HCA (H-HCA) are characterized by a marked steatosis and show activation of glycolysis, lipogenesis, translational machinery and mTOR pathway. We studied the consequences of HNF1\u03b1 silencing in hepatic cell lines, HepG2 and Hep3B and we reproduced most of the deregulations identified in H-HCA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We transfected hepatoma cell lines HepG2 and Hep3B with siRNA targeting HNF1\u03b1 and obtained a strong inhibition of HNF1\u03b1 expression. We then looked at the phenotypic changes by microscopy and studied changes in gene expression using qRT-PCR and Western Blot.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hepatocytes transfected with HNF1\u03b1 siRNA underwent severe phenotypic changes with loss of cell-cell contacts and development of migration structures. In HNF1\u03b1-inhibited cells, hepatocyte and epithelial markers were diminished and mesenchymal markers were over-expressed. This epithelial-mesenchymal transition (EMT) was related to the up regulation of several EMT transcription factors, in particular <jats:italic>SNAIL<\/jats:italic> and <jats:italic>SLUG<\/jats:italic>. We also found an overexpression of TGF\u03b21, an EMT initiator, in both cells transfected with HNF1\u03b1 siRNA and H-HCA. Moreover, TGF\u03b21 expression is strongly correlated to HNF1\u03b1 expression in cell models, suggesting regulation of TGF\u03b21 expression by HNF1\u03b1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results suggest that HNF1\u03b1 is not only important for hepatocyte differentiation, but has also a role in the maintenance of epithelial phenotype in hepatocytes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-11-427","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T18:46:06Z","timestamp":1317840366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["HNF1\u03b1 inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines"],"prefix":"10.1186","volume":"11","author":[{"given":"Laura","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rebouissou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Vignjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Bioulac-Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"4827","key":"2924_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.3499668","volume":"238","author":"G Courtois","year":"1987","unstructured":"Courtois G, Morgan JG, Campbell LA, Fourel G, Crabtree GR: Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science. 1987, 238 (4827): 688-692. 10.1126\/science.3499668.","journal-title":"Science"},{"issue":"5662","key":"2924_CR2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.1089769","volume":"303","author":"DT Odom","year":"2004","unstructured":"Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al: Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004, 303 (5662): 1378-1381. 10.1126\/science.1089769.","journal-title":"Science"},{"issue":"4","key":"2924_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0092-8674(00)81033-8","volume":"84","author":"M Pontoglio","year":"1996","unstructured":"Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 1996, 84 (4): 575-585. 10.1016\/S0092-8674(00)81033-8.","journal-title":"Cell"},{"issue":"4","key":"2924_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/86871","volume":"27","author":"DQ Shih","year":"2001","unstructured":"Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, et al: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet. 2001, 27 (4): 375-382. 10.1038\/86871.","journal-title":"Nat Genet"},{"issue":"5","key":"2924_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1128\/MCB.18.5.3059","volume":"18","author":"YH Lee","year":"1998","unstructured":"Lee YH, Sauer B, Gonzalez FJ: Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol. 1998, 18 (5): 3059-3068.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2924_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJM197602262940904","volume":"294","author":"HA Edmondson","year":"1976","unstructured":"Edmondson HA, Henderson B, Benton B: Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976, 294 (9): 470-472. 10.1056\/NEJM197602262940904.","journal-title":"N Engl J Med"},{"issue":"2","key":"2924_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng1001","volume":"32","author":"O Bluteau","year":"2002","unstructured":"Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, Franco D, Balabaud C, Laurent-Puig P, et al: Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002, 32 (2): 312-315. 10.1038\/ng1001.","journal-title":"Nat Genet"},{"issue":"3","key":"2924_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep.21068","volume":"43","author":"J Zucman-Rossi","year":"2006","unstructured":"Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, et al: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006, 43 (3): 515-524. 10.1002\/hep.21068.","journal-title":"Hepatology"},{"issue":"3","key":"2924_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/hep.21743","volume":"46","author":"P Bioulac-Sage","year":"2007","unstructured":"Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, et al: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007, 46 (3): 740-748. 10.1002\/hep.21743.","journal-title":"Hepatology"},{"issue":"7226","key":"2924_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature07475","volume":"457","author":"S Rebouissou","year":"2009","unstructured":"Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J: Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009, 457 (7226): 200-204. 10.1038\/nature07475.","journal-title":"Nature"},{"key":"2924_CR11","volume-title":"J Hepatol","author":"JC Nault","year":"2011","unstructured":"Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Van Nhieu JT, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, et al: GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2011"},{"issue":"7","key":"2924_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1084\/jem.20110283","volume":"208","author":"C Pilati","year":"2011","unstructured":"Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, et al: Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011, 208 (7): 1359-1366. 10.1084\/jem.20110283.","journal-title":"J Exp Med"},{"issue":"5","key":"2924_CR13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.gastro.2003.07.012","volume":"125","author":"Y Bacq","year":"2003","unstructured":"Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A, et al: Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 2003, 125 (5): 1470-1475. 10.1016\/j.gastro.2003.07.012.","journal-title":"Gastroenterology"},{"issue":"5","key":"2924_CR14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/0016-5085(85)90220-3","volume":"89","author":"JF Flejou","year":"1985","unstructured":"Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP: Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology. 1985, 89 (5): 1132-1138.","journal-title":"Gastroenterology"},{"issue":"3","key":"2924_CR15","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1210\/jc.2003-031552","volume":"89","author":"Y Reznik","year":"2004","unstructured":"Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S, Rousselot P, Fabre M, Oberti F, Fatome A, et al: Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab. 2004, 89 (3): 1476-1480. 10.1210\/jc.2003-031552.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2924_CR16","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2337\/db09-1819","volume":"59","author":"E Jeannot","year":"2010","unstructured":"Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Tran Van Nhieu J, Bacq Y, Michalak S, Buob D, Laurent-Puig P, et al: Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes. 2010, 59 (7): 1836-1844. 10.2337\/db09-1819.","journal-title":"Diabetes"},{"issue":"2","key":"2924_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hep.23362","volume":"51","author":"L Pelletier","year":"2010","unstructured":"Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J: Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 2010, 51 (2): 557-566.","journal-title":"Hepatology"},{"issue":"19","key":"2924_CR18","doi-asserted-by":"publisher","first-page":"14437","DOI":"10.1074\/jbc.M610725200","volume":"282","author":"S Rebouissou","year":"2007","unstructured":"Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Terce F, Auffray C, Bioulac-Sage P, Zucman-Rossi J: HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem. 2007, 282 (19): 14437-14446. 10.1074\/jbc.M610725200.","journal-title":"J Biol Chem"},{"issue":"5","key":"2924_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/hmg\/ddi057","volume":"14","author":"S Rebouissou","year":"2005","unstructured":"Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, Chretien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, et al: Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet. 2005, 14 (5): 603-614. 10.1093\/hmg\/ddi057.","journal-title":"Hum Mol Genet"},{"issue":"16","key":"2924_CR20","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1101\/gad.390906","volume":"20","author":"I Kyrmizi","year":"2006","unstructured":"Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I: Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 2006, 20 (16): 2293-2305. 10.1101\/gad.390906.","journal-title":"Genes Dev"},{"issue":"11","key":"2924_CR21","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1128\/MCB.14.11.7276","volume":"14","author":"W Zhong","year":"1994","unstructured":"Zhong W, Mirkovitch J, Darnell JE: Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol Cell Biol. 1994, 14 (11): 7276-7284.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2924_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006, 172 (7): 973-981. 10.1083\/jcb.200601018.","journal-title":"J Cell Biol"},{"issue":"6","key":"2924_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003, 15 (6): 740-746. 10.1016\/j.ceb.2003.10.006.","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"2924_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038\/nrm1835.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2924_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","volume":"17","author":"MA Huber","year":"2005","unstructured":"Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005, 17 (5): 548-558. 10.1016\/j.ceb.2005.08.001.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"2924_CR26","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/hep.22283","volume":"47","author":"C Coulouarn","year":"2008","unstructured":"Coulouarn C, Factor VM, Thorgeirsson SS: Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology. 2008, 47 (6): 2059-2067. 10.1002\/hep.22283.","journal-title":"Hepatology"},{"issue":"6958","key":"2924_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003, 425 (6958): 577-584. 10.1038\/nature02006.","journal-title":"Nature"},{"issue":"31","key":"2924_CR28","doi-asserted-by":"publisher","first-page":"28003","DOI":"10.1074\/jbc.M106837200","volume":"277","author":"PC Billings","year":"2002","unstructured":"Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, Howard PS, Rosenbloom J: The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem. 2002, 277 (31): 28003-28009. 10.1074\/jbc.M106837200.","journal-title":"J Biol Chem"},{"issue":"1","key":"2924_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2337\/diabetes.51.1.114","volume":"51","author":"K Yamagata","year":"2002","unstructured":"Yamagata K, Nammo T, Moriwaki M, Ihara A, Iizuka K, Yang Q, Satoh T, Li M, Uenaka R, Okita K, et al: Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes. 2002, 51 (1): 114-123.","journal-title":"Diabetes"},{"issue":"24","key":"2924_CR30","doi-asserted-by":"publisher","first-page":"21361","DOI":"10.1074\/jbc.M110261200","volume":"277","author":"T Sakaguchi","year":"2002","unstructured":"Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC: Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem. 2002, 277 (24): 21361-21370. 10.1074\/jbc.M110261200.","journal-title":"J Biol Chem"},{"issue":"2","key":"2924_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0003-9861(02)00488-5","volume":"407","author":"LD Koffler","year":"2002","unstructured":"Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch RJ: Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1alpha. Arch Biochem Biophys. 2002, 407 (2): 160-167. 10.1016\/S0003-9861(02)00488-5.","journal-title":"Arch Biochem Biophys"},{"issue":"13","key":"2924_CR32","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1093\/nar\/19.13.3553","volume":"19","author":"I Bach","year":"1991","unstructured":"Bach I, Mattei MG, Cereghini S, Yaniv M: Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res. 1991, 19 (13): 3553-3559. 10.1093\/nar\/19.13.3553.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2924_CR33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/j.1460-2075.1991.tb07664.x","volume":"10","author":"V De Simone","year":"1991","unstructured":"De Simone V, De Magistris L, Lazzaro D, Gerstner J, Monaci P, Nicosia A, Cortese R: LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 1991, 10 (6): 1435-1443.","journal-title":"EMBO J"},{"issue":"12","key":"2924_CR34","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1593\/neo.81004","volume":"10","author":"A Tomassetti","year":"2008","unstructured":"Tomassetti A, De Santis G, Castellano G, Miotti S, Mazzi M, Tomasoni D, Van Roy F, Carcangiu ML, Canevari S: Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells. Neoplasia. 2008, 10 (12): 1481-1492. 1483p following 1492","journal-title":"Neoplasia"},{"issue":"3","key":"2924_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm757","volume":"3","author":"MA Nieto","year":"2002","unstructured":"Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002, 3 (3): 155-166.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5-6","key":"2924_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1387\/ijdb.041794hp","volume":"48","author":"H Peinado","year":"2004","unstructured":"Peinado H, Portillo F, Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004, 48 (5-6): 365-375. 10.1387\/ijdb.041794hp.","journal-title":"Int J Dev Biol"},{"key":"2924_CR37","volume-title":"Hepatology","author":"L Santangelo","year":"2011","unstructured":"Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, Bonzo JA, Gonzalez FJ, Alonzi T, Amicone L, et al: The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4alpha. Hepatology. 2011"},{"issue":"6359","key":"2924_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/355457a0","volume":"355","author":"CJ Kuo","year":"1992","unstructured":"Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree GR: A transcriptional hierarchy involved in mammalian cell-type specification. Nature. 1992, 355 (6359): 457-461. 10.1038\/355457a0.","journal-title":"Nature"},{"issue":"Pt 16","key":"2924_CR39","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1242\/jcs.111.16.2411","volume":"111","author":"A Bailly","year":"1998","unstructured":"Bailly A, Spath G, Bender V, Weiss MC: Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell. J Cell Sci. 1998, 111 (Pt 16): 2411-2421.","journal-title":"J Cell Sci"},{"issue":"5322","key":"2924_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1126\/science.277.5322.109","volume":"277","author":"E Ktistaki","year":"1997","unstructured":"Ktistaki E, Talianidis I: Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science. 1997, 277 (5322): 109-112. 10.1126\/science.277.5322.109.","journal-title":"Science"},{"issue":"22","key":"2924_CR41","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.1073\/pnas.0600246103","volume":"103","author":"MA Battle","year":"2006","unstructured":"Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA: Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA. 2006, 103 (22): 8419-8424. 10.1073\/pnas.0600246103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2924_CR42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1083\/jcb.140.4.935","volume":"140","author":"GF Spath","year":"1998","unstructured":"Spath GF, Weiss MC: Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol. 1998, 140 (4): 935-946. 10.1083\/jcb.140.4.935.","journal-title":"J Cell Biol"},{"key":"2924_CR43","volume-title":"J Vet Med Sci","author":"T Kanazawa","year":"2010","unstructured":"Kanazawa T, Ichii O, Otsuka S, Namiki Y, Hashimoto Y, Kon Y: Hepatocyte Nuclear Factor 4 Alpha Is Associated with Mesenchymal-Epithelial Transition in Developing Kidneys of C57BL\/6 Mice. J Vet Med Sci. 2010"},{"issue":"22","key":"2924_CR44","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/sj.onc.1209083","volume":"25","author":"J Gotzmann","year":"2006","unstructured":"Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, et al: A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006, 25 (22): 3170-3185. 10.1038\/sj.onc.1209083.","journal-title":"Oncogene"},{"issue":"1","key":"2924_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jcp.20730","volume":"209","author":"C Cicchini","year":"2006","unstructured":"Cicchini C, Filippini D, Coen S, Marchetti A, Cavallari C, Laudadio I, Spagnoli FM, Alonzi T, Tripodi M: Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J Cell Physiol. 2006, 209 (1): 230-238. 10.1002\/jcp.20730.","journal-title":"J Cell Physiol"},{"issue":"2","key":"2924_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","volume":"21","author":"CH Heldin","year":"2009","unstructured":"Heldin CH, Landstrom M, Moustakas A: Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009, 21 (2): 166-176. 10.1016\/j.ceb.2009.01.021.","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"2924_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki Y, Okazaki I: Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007, 56 (2): 284-292. 10.1136\/gut.2005.088690.","journal-title":"Gut"},{"issue":"1","key":"2924_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.gastro.2009.03.035","volume":"137","author":"FP Lemaigre","year":"2009","unstructured":"Lemaigre FP: Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 2009, 137 (1): 62-79. 10.1053\/j.gastro.2009.03.035.","journal-title":"Gastroenterology"},{"issue":"2","key":"2924_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4161\/cc.5.2.2341","volume":"5","author":"F Clotman","year":"2006","unstructured":"Clotman F, Lemaigre FP: Control of hepatic differentiation by activin\/TGFbeta signaling. Cell Cycle. 2006, 5 (2): 168-171. 10.4161\/cc.5.2.2341.","journal-title":"Cell Cycle"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-427\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:55:51Z","timestamp":1630616151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-427","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]},"assertion":[{"value":"4 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"427"}}